In the single-marker analysis, increased density of CD66b+ TANs in the central tumor, but also in adjacent normal tissue and the lymph nodes, was predictive of reduced disease-free survival in early luminal breast cancer. The gene discussed is CEACAM8; the disease is breast carcinoma.